首页>
外国专利>
Method for predicting therapeutic effect on colorectal cancer patients with enhanced expression of TK1 protein
Method for predicting therapeutic effect on colorectal cancer patients with enhanced expression of TK1 protein
展开▼
机译:TK1蛋白表达增强对大肠癌患者疗效的预测方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides a method for predicting the therapeutic effect of chemotherapy using an antitumor agent containing trifluridine and tipiracil hydrochloride at a molar ratio of 1:0.5 on a colorectal cancer patient, the method comprising the following steps (1) to (3). As the means for solving the problem, the following invention is provided: a method comprising (1) detecting the expression of TK1 protein by an immunohistochemical method in tumor cells contained in a biological sample obtained from the patient; (2) based on the detection results obtained in step (1), classifying the tumor cells into positive cells and negative cells, and calculating the percentage of positive cells in the tumor cells; and (3) based on the calculation results obtained in step (2), predicting that when the percentage is 30% or more, the patient is likely to sufficiently respond to chemotherapy using the antitumor agent containing trifluridine and tipiracil hydrochloride at a molar ratio of 1:0.5.
展开▼